Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronate.
We describe the case of a 70-year-old man with unicentric grade 1 epitheloid hemangioendothelioma (EH) of the bone that favourably responded to intravenous pamidronate as a single agent. After 6 years of follow-up, the patient was in complete remisssion. We suggest that use of bisphosphonates should be considered in the treatment of osteolytic EH.
Coppo
P
P
Service d'lmmunologie, Faculté de Médecine d'Amiens, Amiens, France.
Lassoued
S
S
Billey
T
T
Lassoued
K
K
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005385:Fingers / Q000473:pathology; D006390:Hemangioendothelioma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D010014:Osteolysis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D000077268:Pamidronate; D011859:Radiography; D016896:Treatment Outcome; D014953:Wrist / Q000473:pathology
D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate